Working together for a healthier world®
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.


Mission Bay Capital is an independent venture firm focused on making pivotal, early-stage investments in bioscience companies emerging from the University of California. Founded in June 2009, Mission Bay Capital combines the rich knowledge and navigation skills of QB3 executives—Regis Kelly, Douglas Crawford, and Neena Kadaba—with the experience and proven success of a renowned investment advisory committee led by Brook Byers and John Wadsworth. Mission Bay Capital is fueling breakthrough bioscience technologies to meet society’s challenges while also helping to boost the California economy.


ShangPharma Innovation is a global innovation incubator and investment organization focused on biomedical R&D technologies and therapeutics.
We believe Innovation is the only way to make a difference in peoples’ lives, the lives of patients and caregivers and the lives of our collaborators and partners.


The WI Harper Group is a cross border venture fund with $1 Billion of assets under management focusing on technology and healthcare investments in the U.S. and Greater China. From our offices in Beijing, Taipei, and San Francisco, we seek to back visionary entrepreneurs who are building disruptive companies. We look for promising early-stage technology and healthcare companies where we can add value through our extensive network and platform. Our track record and strategic relationships in the US and Greater China uniquely position us to best assist entrepreneurs looking to expand across these two markets.


Elements Capital is dedicated to backing visionary biotechnology and healthcare entrepreneurs and technologies. We focus on bridging Sino-US market opportunities across healthcare, including drug discovery and development, health informatics, pathology labs and big-data platforms. We bring an industry-driven perspective and value proposition to our portfolio companies, including support from Elements’ in-house China resources and connections to our expanding global network.


Perseverance Capital is an investment management firm pursuing an evidence-based investment approach with a global mandate exclusively in the healthcare sector. We have a particular interest in oncology and invest in companies across all equity stages.